ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

XRTX XORTX Therapeutics Inc

2.36
-0.08 (-3.28%)
Dec 01 2023 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 21,025
Bid Price 1.99
Ask Price 2.31
News -
Day High 2.49

Low
2.06

52 Week Range

High
11.16

Day Low 2.2095
Company Name Stock Ticker Symbol Market Type
XORTX Therapeutics Inc XRTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.08 -3.28% 2.36 20:00:00
Open Price Low Price High Price Close Price Prev Close
2.37 2.2095 2.49 2.3305 2.44
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
240 21,025 $ 2.38 $ 50,110 - 2.06 - 11.16
Last Trade Time Type Quantity Stock Price Currency
19:58:44 20 $ 2.31 USD

XORTX Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
4.66M 2.00M - 0 -9.49M -4.75 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

XORTX Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No XRTX Message Board. Create One! See More Posts on XRTX Message Board See More Message Board Posts

Historical XRTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.553.102.062.6542,075-0.19-7.45%
1 Month3.20494.322.062.89148,741-0.8449-26.36%
3 Months5.72227.5242.065.291,938,384-3.36-58.76%
6 Months5.98057.5242.065.31922,327-3.62-60.54%
1 Year7.8311.162.066.01703,746-5.47-69.86%
3 Years31.3253.012.0613.99538,924-28.96-92.46%
5 Years31.3253.012.0613.99538,924-28.96-92.46%

XORTX Therapeutics Description

XORTX Therapeutics Inc is a clinical-stage biotechnology company. The company focused on developing drug therapies for orphan diseases like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com